Predictors of Cardiometabolic Health a Few Months Postpartum in Women Who Had Developed Gestational Diabetes
Gómez Fernández C. et al, (2025), Nutrients, 17, 390 - 390
Enhancing postpartum cardiometabolic health for women with previous gestational diabetes: Next steps and unanswered questions for pharmacological and lifestyle strategies
Golubic R. et al, (2024), Diabetes, Obesity and Metabolism
Abstract 4144972: Predictors of cardiovascular disease risk and total mortality: Findings from the UK Biobank.
Agwara EO. et al, (2024), Circulation, 150
Predictors of cardiovascular disease risk: findings from the National Survey of Health and Development Cohort
Agwara E. et al, (2024), European Heart Journal, 45
Dual glucagon-like peptide-1 and glucagon receptor agonism reduces energy intake in type 2 diabetes with obesity.
Golubic R. et al, (2024), Diabetes Obes Metab
Sumatriptan, a serotonin 5HT1B receptor agonist, acutely reduces insulin secretion and sensitivity and glucose effectiveness in overweight humans: A double‐blinded placebo‐controlled cross‐over trial
Golubic R. et al, (2023), Diabetes, Obesity and Metabolism
Non-occupational physical activity and risk of cardiovascular disease, cancer and mortality outcomes: a dose–response meta-analysis of large prospective studies
Garcia L. et al, (2023), British Journal of Sports Medicine
Do markers of adiposity and glycaemia mediate the association between low carbohydrate diet and cardiovascular risk factors: Findings from the UK National Diet and Nutrition Survey (NDNS) 2008-2016
Tramontt CR. et al, (2023), BMJ Nutrition, Prevention and Health
Glucocorticoid-induced hyperglycaemia and diabetes: Call for action.
Golubic R. et al, (2022), Diabet Med, 39
Obesity definition for personalised treatment of type 2 diabetes.
Golubic R. et al, (2022), Lancet, 399
Association Between Physical Activity and Risk of Depression: A Systematic Review and Meta-analysis.
Pearce M. et al, (2022), JAMA Psychiatry, 79, 550 - 559
Sumatriptan exerts glucoregulatory effects in humans
Golubic R. et al, (2022), DIABETIC MEDICINE, 39
A synthesis of pathways linking diet, metabolic risk and cardiovascular disease: a framework to guide further research and approaches to evidence-based practice.
Lima do Vale MR. et al, (2021), Nutr Res Rev, 1 - 27
Dual GLP-1 and glucagon receptor agonism with cotadutide significantly increases insulin secretion in overweight and obese adults with type 2 diabetes
Golubic R. et al, (2021), DIABETOLOGIA, 64, 239 - 239
Ethnic inclusivity and preventative health research in addressing health inequalities and developing evidence base.
Osuafor CN. et al, (2021), EClinicalMedicine, 31
Steroid induced diabetes or glutamic acid decarboxylase 65 KD (GAD65) antibody positive type 1 diabetes: A diagnostic dilemma in common variable immunodeficiency
Golubic R. et al, (2021), DIABETIC MEDICINE, 38
Insights from a general practice service evaluation supporting a lower carbohydrate diet in patients with type 2 diabetes mellitus and prediabetes: a secondary analysis of routine clinic data including HbA1c, weight and prescribing over 6 years.
Unwin D. et al, (2020), BMJ Nutr Prev Health, 3, 285 - 294